Publication Name	World Journal of Gastroenterology
Manuscript ID	24275
Country	Greece

Received	2016-01-15 08:39
Peer-Review Started	2016-01-18 10:35
To Make the First Decision	2016-01-28 14:22
Return for Revision	2016-01-30 11:26
Revised	2016-02-15 17:51
Second Decision	2016-02-25 18:37
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-03-02 08:02
Articles in Press	2016-03-02 08:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-03-17 17:20
Publish the Manuscript Online	2016-05-17 10:45

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis
Manuscript Source	Unsolicited Manuscript
All Author List	Georgios N Kalambokis, Gerasimos Baltayiannis and Dimitrios Christodoulou
Funding Agency and Grant Number
Corresponding Author	Georgios N Kalambokis, MD, Assistant Professor of Internal Medicine, 1st Division of Internal Medicine, Medical School, University of Ioannina, 45110 Ioannina, Greece. gkalambo@cc.uoi.gr
Key Words	von Willebrand factor antigen; Endothelial dysfunction; Treatment; Portal hypertension
Core Tip	The purpose of this letter to the Editor is to comment on the potential contribution of increased intrahepatic levels of von Willebrand factor as an additional mechanism that could be related to increased portal pressure in patients with cirrhosis and propose drugs which could decrease portal pressure on the basis of von Willebrand factor’s production or effects.
Publish Date	2016-05-17 10:45
Citation	Kalambokis GN, Baltayiannis G, Christodoulou D. von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis. World J Gastroenterol 2016; 22(19): 4786-4788
URL	http://www.wjgnet.com/1007-9327/full/v22/i19/4786.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i19.4786

Full Article (PDF)	WJG-22-4786.pdf
Full Article (Word)	WJG-22-4786.doc
Manuscript File	24275-Review.docx
Answering Reviewers	24275-Answering reviewers.pdf
Audio Core Tip	24275-Audio core tip.wav
Conflict-of-Interest Disclosure Form	24275-Conflict-of-interest statement.pdf
Copyright License Agreement	24275-Copyright assignment.pdf
Peer-review Report	24275-Peer-review(s).pdf
Scientific Misconduct Check	24275-Scientific misconduct check.pdf
Scientific Editor Work List	24275-Scientific editor work list.pdf